Neuroimmun GmbH
Neuroimmun GmbH

References - Immundiagnostik IDO activity ELISA

Dewi DL, Mohapatra SR, Blanco Cabañes S, Adam I, Somarribas Patterson LF, Berdel B, et al.: Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer. Oncoimmunology. 2017;(February):1-12. doi:10.1080/2162402X.2016.1274477

Druckversion Druckversion | Sitemap
© Neuroimmun GmbH